Esperion Therapeutics
ESPR
#6738
Rank
HK$3.78 B
Marketcap
HK$19.22
Share price
2.49%
Change (1 day)
107.19%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -HK$0.32 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.27 Billion. In 2023 the company made an earning of -HK$1.17 Billion, an increase over its 2022 earnings that were of -HK$1.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.32 Billion-72.88%
2023 -HK$1.17 Billion-15.03%
2022 -HK$1.38 Billion-20.61%
2021 -HK$1.74 Billion84.28%
2020 -HK$0.95 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.57 Billion19.57%
2017 -HK$1.31 Billion125.39%
2016 -HK$0.59 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$79.8 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$4.05 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.04 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.44 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$38.66 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.78 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.58 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA